|
BSX Meets With Much Approval, Biogen and Icahn Set the (Showdown) Date, Fate’s Fate Revealed, Win Free Stuff, & More Life Sciences News
|
Rebecca Zacks |
05/14/08 |
|
No Comments
|
|
Biogen Idec Sets Date for Showdown With Icahn, Proxy Battle Begins
|
Robert Buderi |
05/09/08 |
|
No Comments
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
|
No Comments
|
|
Biogen Idec Announces Its Own Director Slate—Digs in Against Icahn
|
Robert Buderi |
04/17/08 |
|
No Comments
|
|
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News
|
Rebecca Zacks |
04/16/08 |
|
No Comments
|
|
Icahn Turns Up Heat, Files Suit to Force Biogen Idec to Turn Over Records of Failed Sale
|
Robert Buderi |
04/09/08 |
|
No Comments
|
|
Exact Sciences Puts Itself on the Block After Investor’s Prodding
|
Rebecca Zacks |
03/18/08 |
|
No Comments
|
|
Biogen Bouncing Back From Tysabri Warning News
|
Rebecca Zacks |
02/28/08 |
|
1 Comment
|
|
Fearing Icahn’s Impact on Morale, Biogen Idec Launches Key Employee Retention Plan
|
Robert Buderi |
02/15/08 |
|
No Comments
|
|
Icahn Dumps Genzyme Position
|
Robert Buderi |
02/14/08 |
|
1 Comment
|
|
Barbs of Wisdom: Carl Icahn to Start Blogging
|
Robert Buderi |
02/06/08 |
|
No Comments
|
|
An Analysis of Icahn’s Biogen Idec Strategy: Why Three Board Seats When Four Will Be Open?
|
Robert Buderi |
01/31/08 |
|
No Comments
|
|
MIT Teams With Italian Energy Giant, Elixir Postpones Its IPO, Biogen Idec Will Buy or Be Bought, & More
|
Rebecca Zacks |
01/23/08 |
|
No Comments
|
|
Perceived Risk, Culture Clash Did in Biogen Idec Sale, CEO Asserts
|
Henry Johnson |
01/11/08 |
|
2 Comments
|
|
The Xconomy Half-Dozen-Stories-of-the-Half-Year Awards
|
Rebecca Zacks |
12/27/07 |
|
1 Comment
|
|
Biogen Idec-Icahn Story Likely Far From Over; History Says the Activist Investor Will Act Again
|
Robert Buderi |
12/18/07 |
|
No Comments
|
|
Going Up Against Henri—Genzyme Not For Sale
|
Robert Buderi |
12/06/07 |
|
No Comments
|
|
Carl Icahn Ups Biogen Idec Stake—Now Owns 3 Percent; Also Buys Shares in Genzyme
|
Robert Buderi |
11/14/07 |
|
No Comments
|
|
Biogen Idec Shares Push Upward on Down Day for Market: More Grist for the Takeover Mill
|
Robert Buderi |
11/08/07 |
|
No Comments
|
|
Bidding for Biogen Idec Could Begin in Early November, Report Says
|
Robert Buderi |
10/26/07 |
|
No Comments
|
|
Biogen-Icahn? Pfiz-ogen or Pfiz-zyme? Is All of Cambridge Biotech Suddenly Up For Sale?
|
Robert Buderi |
10/24/07 |
|
No Comments
|
|
Icahn Offered $23 Billion for Biogen Idec—Elan Won’t Block Sale
|
Robert Buderi |
10/15/07 |
|
2 Comments
|
|
Biogen Idec on the Block; Icahn’s Interest in Buying the Firm Confirmed
|
Rebecca Zacks |
10/12/07 |
|
No Comments
|
|
Carl Icahn: Biogen Idec Marriage Broker?
|
Robert Buderi |
08/27/07 |
|
No Comments
|
|
Icahn Gets Okay to Purchase Biogen Idec Shares
|
Robert Buderi |
08/25/07 |
|
No Comments
|
